Controlling ADHD

June 22, 2004

PHILADELPHIA, PA, June 22, 2004 -Attention deficit hyperactivity disorder (ADHD) is the most common behavioral disorder in children; it adversely affects performance in school and emotional development, and the symptoms can continue into adulthood.

Researchers at the Department of Nuclear Medicine, University of Munich, investigated a method to predict which ADHD patients will not respond to Ritalin therapy by measuring the degree to which [Tc?99m]TRODAT-1, a radiolabled protein, binds to the dopamine transporter. The study used single photon emission computed tomography (SPECT) to quantify the degree of binding. They delivered the results of their study on June 22 at the Society of Nuclear Medicine's 51st Annual Meeting in Philadelphia.

Ritalin works by blocking the dopamine transporter, increasing dopamine levels in the brain. But this treatment is often controversial because it can involve long-term drug therapy in children. Because 20%-30% of patients with ADHD do not respond to Ritalin therapy, a method of predicting therapeutic response would reduce exposure of ADHD patients to a drug that is unlikely to be effective.

Initial symptoms and post-therapy symptoms were measured in 18 adult ADHD patients using the Clinical Global Impressions (CGI) scale. Of the 13 patients who showed high levels of dopamine transporter binding, 12 demonstrated a significant improvement of ADHD symptoms on Ritalin. Conversely, none of the 5 patients who showed reduced levels of dopamine transporter binding responded to Ritalin therapy.

According to Dr. Christian la Fougère, the presenting author of the study, "Our results indicate that measurement of dopamine transporter may be an important prognostic predictor for therapeutic response to Ritalin."

Dr. la Fougère went on to speculate, "If we can determine who will respond to the drug and who will not respond, then only those patients who will benefit will be treated with Ritalin. Moreover, we can begin to examine alternative methods to treat the ADHD patients who do not respond to Ritalin."
The Society of Nuclear Medicine is holding its 51st Annual Meeting June 19-23, 2004, at the Pennsylvania Convention Center in downtown Philadelphia. Hot topics for the 2004 meeting include techniques for the early diagnosis of Alzheimer's disease; advanced imaging for the diagnosis, staging, and treatment of cancer; nuclear cardiology; and the collaboration between nuclear medicine and bioengineering in the fight against cancer.

Society of Nuclear Medicine

Related ADHD Articles from Brightsurf:

Autism and ADHD share genes
Researchers from the national psychiatric project iPSYCH have found that autism and ADHD share changes in the same genes.

ADHD across racial/ethnic groups
This study of patients from diverse racial/ethnic backgrounds who received care at the Kaiser Permanente Northern California health system looked at how common attention-deficit/hyperactivity disorder (ADHD) diagnoses were over a 10-year period across seven racial/ethnic groups.

Cycles of reward: New insight into ADHD treatment
Researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) in collaboration with scientists at the University of Otago and the University of Auckland in New Zealand, investigated the actions of the drug in rats.

Young mums more likely to have kids with ADHD
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder (ADHD) according to new research from the University of South Australia.

ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.

Antipsychotic use in youths with ADHD is low, but still cause for concern
A new study eased fears about the proportion of youths with ADHD taking antipsychotic drugs, but still found that many prescriptions may be inappropriate.

How stimulant treatment prevents serious outcomes of ADHD
Analysis quantifies the extent which stimulant treatment reduces serious outcomes in children and young adults with ADHD.

Did Leonardo da Vinci have ADHD?
Leonardo da Vinci produced some of the world's most iconic art, but historical accounts show that he struggled to complete his works.

More sleep may help teens with ADHD focus and organize
Teenagers with attention deficit hyperactivity disorder (ADHD) may benefit from more sleep to help them focus, plan and control their emotions.

Researchers have found the first risk genes for ADHD
A major international collaboration headed by researchers from the Danish iPSYCH project, the Broad Institute of Harvard and MIT, Massachusetts General Hospital, SUNY Upstate Medical University, and the Psychiatric Genomics Consortium has for the first time identified genetic variants which increase the risk of ADHD.

Read More: ADHD News and ADHD Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to